EP4065119
INITIAL TRIPLE COMBINATION THERAPY WITH MACITENTAN, TADALAFIL, AND SELEXIPAG FOR TREATING PULMONARY ARTERIAL HYPERTENSION
:
EP einkaleyfi: Þýðing ekki lögð inn:
27.11.2020:
4.9.2024:
20820054.3
:
26.11.2040
:
INITIAL TRIPLE COMBINATION THERAPY WITH MACITENTAN, TADALAFIL, AND SELEXIPAG FOR TREATING PULMONARY ARTERIAL HYPERTENSION
27.11.2020
4.9.2024
:
Actelion Pharmaceuticals Ltd:
Gewerbestrasse 16, 4123 Allschwil, CH
:
MARESTA, Alessandro:
4123 Allschwil, CH
:
PERCHENET, Loïc:
4123 Allschwil, CH
:
201962941910 P:
29.11.2019:
US
:
202063023452 P:
12.5.2020:
US
:
202063076149 P:
9.9.2020:
US
:
EP2020083593:
27.11.2020
:
A61K 31/4965, A61K 31/4985, A61K 31/505, A61K 31/506, A61K 31/519, A61K 31/53, A61P 9/12, A61K 45/06